Effects of serum and autologous conditioned serum on equine articular chondrocytes treated with interleukin-1β.

This study examines and compares the metabolic effects of autologous equine serum (AES) and autologous conditioned serum (ACS) on equine articular chondrocytes (cartilage cells) when exposed to human interleukin (IL)-1β. The research concludes that ACS treatment shows minimal advantageous effects on the proteoglycan matrix metabolism in equine chondrocytes compared to AES treatment.

Methods and Experimental Design

• The researchers used articular cartilage and both non-conditioned and conditioned serum from six adult horses for the study.
• The cartilage samples were digested, and the chondrocytes were isolated and formed into pellets for experimentation.
• These chondrocytes pellets were treated with varying concentrations (10% and 20%) of AES and ACS in combination with recombinant human interleukin-1β.
• The effects of these treatments on various cellular and molecular parameters were measured and compared.

Outcomes and Interpretations

• The study discovered that the treatment with recombinant human IL-1β led to a decrease in chondrocyte glycosaminoglycan synthesis and collagen II mRNA expression and an increase in medium matrix metalloproteinase-3 activity and cyclooxygenase-2 mRNA expression.
• When the results of ACS and rhIL-1β treatment were compared with those of AES and rhIL-1β treatment, no significant difference was observed in glycosaminoglycan release, total glycosaminoglycan concentration, total DNA content, or matrix metalloproteinase-3 activity.
• A considerable increase was found in chondrocyte glycosaminoglycan synthesis with 20% AES and rhIL-1β as compared to 10% ACS and rhIL-1β.
• Medium from ACS and rhIL-1β treatment displayed a higher concentration of IL-1β receptor antagonist compared to medium from AES and rhIL-1β treatment. This might suggest greater anti-inflammatory effects of ACS.
• Treatment with 20% ACS and rhIL-1β resulted in a higher medium insulin-like growth factor-I concentration than the treatment with 10% AES and rhIL-1β. This suggests the potential of ACS to stimulate chondrocyte growth and cartilage repair to a better extent than AES.
• However, there was no difference in mRNA expression found between ACS and rhIL-1β treatment and AES and rhIL-1β treatment.
• In conclusion, this study only found minimal beneficial effects of ACS treatment on proteoglycan matrix metabolism in equine chondrocytes compared to AES treatment.